Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Pharmacokinetics and Safety of Letermovir in Pediatric HSCT Recipients
NCT03940586Phase 2Completed
- Sponsor
- Merck & Co.
- Start
- Aug 2019
- Primary completion
- Jan 2023
- Modality
- Small Molecules
- Countries
- 11
01
Overview
A Phase 2 trial of letermovir in cytomegalovirus infection (CMV), sponsored by Merck & Co.. Started Aug 2019; status: completed.
02
Drugs
letermovir
03
Conditions
cytomegalovirus infection (CMV)
Beyond the preview
Go deeper on NCT03940586.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03940586.